Literature DB >> 22573733

Fragment screening using capillary electrophoresis (CEfrag) for hit identification of heat shock protein 90 ATPase inhibitors.

Carol Austin1, Simon N Pettit, Sharon K Magnolo, Jonathan Sanvoisin, Wenjie Chen, Stephen P Wood, Lauren D Freeman, Reuben J Pengelly, Dallas E Hughes.   

Abstract

CEfrag is a new fragment screening technology based on affinity capillary electrophoresis (ACE). Here we report on the development of a mobility shift competition assay using full-length human heat shock protein 90α (Hsp90α), radicicol as the competitor probe ligand, and successful screening of the Selcia fragment library. The CEfrag assay was able to detect weaker affinity (IC(50) >500 µM) fragments than were detected by a fluorescence polarization competition assay using FITC-labeled geldanamycin. The binding site of selected fragments was determined by co-crystallization with recombinant Hsp90α N-terminal domain and X-ray analysis. The results of this study confirm that CEfrag is a sensitive microscale technique enabling detection of fragments binding to the biological target in near-physiological solution.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573733     DOI: 10.1177/1087057112445785

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  10 in total

1.  A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.

Authors:  Alexander L Perryman; Weixuan Yu; Xin Wang; Sean Ekins; Stefano Forli; Shao-Gang Li; Joel S Freundlich; Peter J Tonge; Arthur J Olson
Journal:  J Chem Inf Model       Date:  2015-02-17       Impact factor: 4.956

Review 2.  Advances in capillary electrophoresis and the implications for drug discovery.

Authors:  Claire M Ouimet; Cara I D'amico; Robert T Kennedy
Journal:  Expert Opin Drug Discov       Date:  2016-12-09       Impact factor: 6.098

3.  Using Fragment-Based Approaches to Discover New Antibiotics.

Authors:  Bas Lamoree; Roderick E Hubbard
Journal:  SLAS Discov       Date:  2018-07       Impact factor: 3.341

Review 4.  Theory and applications of differential scanning fluorimetry in early-stage drug discovery.

Authors:  Kai Gao; Rick Oerlemans; Matthew R Groves
Journal:  Biophys Rev       Date:  2020-01-31

5.  DROIDS 3.0-Detecting Genetic and Drug Class Variant Impact on Conserved Protein Binding Dynamics.

Authors:  Gregory A Babbitt; Ernest P Fokoue; Joshua R Evans; Kyle I Diller; Lily E Adams
Journal:  Biophys J       Date:  2019-12-18       Impact factor: 4.033

6.  Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity.

Authors:  Luca Pinzi; Francesca Foschi; Michael S Christodoulou; Daniele Passarella; Giulio Rastelli
Journal:  ChemistryOpen       Date:  2021-10-11       Impact factor: 2.630

Review 7.  Inhibitors of the Plasmodium falciparum Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future.

Authors:  Melissa Louise Stofberg; Celine Caillet; Marianne de Villiers; Tawanda Zininga
Journal:  Cells       Date:  2021-10-22       Impact factor: 6.600

8.  Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design.

Authors:  Arun Chandramohan; Srinath Krishnamurthy; Andreas Larsson; Paer Nordlund; Anna Jansson; Ganesh S Anand
Journal:  PLoS Comput Biol       Date:  2016-06-02       Impact factor: 4.475

Review 9.  NMR-Fragment Based Virtual Screening: A Brief Overview.

Authors:  Meenakshi Singh; Benjamin Tam; Barak Akabayov
Journal:  Molecules       Date:  2018-01-25       Impact factor: 4.411

10.  Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response.

Authors:  David M Wilson; Ashley M Deacon; Matthew A J Duncton; Patricia Pellicena; Millie M Georgiadis; Andrew P Yeh; Andrew S Arvai; Davide Moiani; John A Tainer; Debanu Das
Journal:  Prog Biophys Mol Biol       Date:  2020-10-25       Impact factor: 3.667

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.